Good morning :)
Place Order
Add to Watchlist

GPT Healthcare Ltd

GPTHEALTH Share Price

146.440.85% (-1.26)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹1,211 cr, stock is ranked 1,348

Stock is 2.72x as volatile as Nifty

GPTHEALTH Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹1,211 cr, stock is ranked 1,348

Stock is 2.72x as volatile as Nifty

GPTHEALTH Performance & Key Metrics

GPTHEALTH Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
24.265.551.02%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.656.550.84%

GPTHEALTH Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
0%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

GPTHEALTH Company Profile

GPT Healthcare is engaged in the operation of multidisciplinary private hospitals and pharmacies.

Investor Presentation

View older View older 

May 23, 2025

PDF
View Older Presentations

GPTHEALTH Similar Stocks (Peers)

Compare with peers Compare with peers 

GPTHEALTH Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
106.78
106.78
1Y Return
30.86%
30.86%
Buy Reco %
75.00
75.00
PE Ratio
68.95
68.95
1Y Return
11.33%
11.33%
Buy Reco %
89.29
89.29
PE Ratio
74.01
74.01
1Y Return
53.80%
53.80%
Buy Reco %
100.00
100.00
PE Ratio
48.94
48.94
1Y Return
53.78%
53.78%
Buy Reco %
87.50
87.50
PE Ratio
65.39
65.39
1Y Return
14.69%
14.69%
Buy Reco %
71.43
71.43
Compare with Peers

GPTHEALTH Sentiment Analysis

GPTHEALTH Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

GPTHEALTH Stock Summary · May 2025

GPT Healthcare Limited reported a modest 2% revenue growth in Q4 FY-25, despite facing a 1% decline in EBITDA due to increased hospital expenses and impairment provisioning. The commissioning of a new 158-bed hospital in Raipur marks a significant step in expanding access to healthcare, with plans for a 150-bed facility in Jamshedpur to support a broader goal of establishing a 1,000-bed hospital chain. While the company has achieved net debt-free status, enhancing financial flexibility, challenges persist with flat volume growth and low occupancy rates in certain hospitals. Strategic initiatives, including a focus on specialized services and a shift towards cash and insurance patients, are expected to drive future revenue growth, although external factors continue to impact overall performance. Management remains optimistic about achieving an EBITDA margin of 22.5% to 23%, despite anticipated losses from new hospital operations.

GPTHEALTH Stock Growth Drivers
GPTHEALTH Stock Growth Drivers
6
  • Expansion of Healthcare Facilities

    The company has successfully commissioned a new 158-bed hospital in Raipur, operational since May 2,

  • Financial Strength and Operational Efficiency

    GPT Healthcare Limited achieved a significant milestone by becoming a net debt-free company, which enhances

GPTHEALTH Stock Challenges
GPTHEALTH Stock Challenges
5
  • Declining Occupancy Rates

    The company is facing persistently low occupancy rates across several hospitals, particularly in Agartala, which

  • Impact of External Factors

    External factors have negatively impacted hospital volumes, particularly in Agartala, where connectivity was hampered for

GPTHEALTH Forecast

GPTHEALTH Forecasts

Price

Revenue

Earnings

GPTHEALTH

GPTHEALTH

Income

Balance Sheet

Cash Flow

GPTHEALTH Income Statement

GPTHEALTH Income Statement

Loading...

Financial YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue216.07248.86342.40366.73405.48415.59415.60
Raw Materialssubtract38.4157.2787.3875.8682.96323.74323.73
Power & Fuel Costsubtract6.196.807.428.089.53
Employee Costsubtract42.0441.6653.7862.0468.93
Selling & Administrative Expensessubtract19.0422.499.3612.9211.84
Operating & Other expensessubtract70.3665.54105.64127.78139.09
Depreciation/Amortizationsubtract11.0812.4713.5914.9117.9819.0319.03
Interest & Other Itemssubtract14.1213.7511.159.167.113.473.47
Taxes & Other Itemssubtract3.887.7912.4116.9620.2719.4319.42
EPS2.033.926.234.885.906.086.09
DPS0.001.830.005.003.501.503.50
Payout ratio0.000.470.001.020.590.250.57

GPTHEALTH Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025FY 2025

Annual Report Pending

Investor Presentation

May 23PDF
Feb 11PDF
Nov 14PDF
FY 2024FY 2024

Annual report

PDF
 

GPTHEALTH Stock Peers

GPTHEALTH Past Performance & Peer Comparison

GPTHEALTH Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
GPT Healthcare Ltd24.285.551.02%
Max Healthcare Institute Ltd106.7813.660.13%
Apollo Hospitals Enterprise Ltd68.9513.620.40%
Fortis Healthcare Ltd74.016.700.13%

GPTHEALTH Stock Price Comparison

Compare GPTHEALTH with any stock or ETF
Compare GPTHEALTH with any stock or ETF
GPTHEALTH
Loading...

GPTHEALTH Holdings

GPTHEALTH Shareholdings

GPTHEALTH Promoter Holdings Trend

GPTHEALTH Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

GPTHEALTH Institutional Holdings Trend

GPTHEALTH Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

GPTHEALTH Shareholding Pattern

GPTHEALTH Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding65.57%6.65%4.70%4.48%18.59%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

GPTHEALTH Shareholding History

GPTHEALTH Shareholding History

FebMarJunSepDec '24Mar7.13%6.68%5.38%4.70%4.72%4.48%

Mutual Funds Invested in GPTHEALTH

Mutual Funds Invested in GPTHEALTH

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding GPT Healthcare Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
1.8143%0.19%-0.04%73/203 (-5)
1.2151%0.19%0.01%38/100 (+6)
1.0111%0.15%-0.01%107/173 (+1)

Compare 3-month MF holding change on Screener

GPTHEALTH Insider Trades & Bulk Stock Deals

GPTHEALTH Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing GPTHEALTH stock

smallcases containing GPTHEALTH stock

Looks like this stock is not in any smallcase yet.

GPTHEALTH Events

GPTHEALTH Events

GPTHEALTH Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

GPTHEALTH Dividend Trend

No dividend trend available

GPTHEALTH Upcoming Dividends

GPTHEALTH Upcoming Dividends

Cash Dividend

Ex DateEx DateJul 29, 2025

Final
Final | Div/Share: ₹1.50

Dividend/Share

1.50

Ex DateEx Date

Jul 29, 2025

GPTHEALTH Past Dividends

GPTHEALTH Past Dividends

Cash Dividend

Ex DateEx DateNov 28, 2024

Interim 1
Interim 1 | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Nov 28, 2024

Cash Dividend

Ex DateEx DateJul 18, 2024

Final
Final | Div/Share: ₹1.50

Dividend/Share

1.50

Ex DateEx Date

Jul 18, 2024

Cash Dividend

Ex DateEx DateApr 2, 2024

Interim 2
Interim 2 | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Apr 2, 2024

GPTHEALTH Stock News & Opinions

GPTHEALTH Stock News & Opinions

Corporate
GPT Healthcare schedules AGM

GPT Healthcare announced that the 36th Annual General Meeting(AGM) of the company will be held on 5 August 2025.Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Board of GPT Healthcare recommends final dividend

GPT Healthcare announced that the Board of Directors of the Company at its meeting held on 23 May 2025, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 15%) , subject to the approval of the shareholders.Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Earnings
GPT Healthcare standalone net profit rises 0.55% in the March 2025 quarter

Net profit of GPT Healthcare rose 0.55% to Rs 12.89 crore in the quarter ended March 2025 as against Rs 12.82 crore during the previous quarter ended March 2024. Sales rose 1.98% to Rs 101.40 crore in the quarter ended March 2025 as against Rs 99.43 crore during the previous quarter ended March 2024. For the full year,net profit rose 4.50% to Rs 49.92 crore in the year ended March 2025 as against Rs 47.77 crore during the previous year ended March 2024. Sales rose 1.72% to Rs 407.09 crore in the year ended March 2025 as against Rs 400.19 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales101.4099.43 2 407.09400.19 2 OPM %20.4123.31 -20.4821.95 - PBDT21.2523.18 -8 88.3886.02 3 PBT16.3718.42 -11 69.3568.04 2 NP12.8912.82 1 49.9247.77 5 Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
GPT Healthcare to convene board meeting

GPT Healthcare will hold a meeting of the Board of Directors of the Company on 23 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
GPT Healthcare standalone net profit rises 6.80% in the December 2024 quarter

Net profit of GPT Healthcare rose 6.80% to Rs 12.25 crore in the quarter ended December 2024 as against Rs 11.47 crore during the previous quarter ended December 2023. Sales rose 5.82% to Rs 102.21 crore in the quarter ended December 2024 as against Rs 96.59 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales102.2196.59 6 OPM %20.8021.74 - PBDT22.2920.49 9 PBT17.6215.99 10 NP12.2511.47 7 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
GPT Healthcare to convene board meeting

GPT Healthcare will hold a meeting of the Board of Directors of the Company on 11 February 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Spotlight
GPT Healthcare gains on inking MoU for new hospital project at Jamshedpur

The facility, which will be fully equipped with modern amenities and services, is intended to be leased to GPT Healthcare on a long-term basis. The agreement involves multiple parties, including Naveen Singh, Ankur Singh, Shruti Singh, Vinayak Singh, Akshat Singh, Avinash Gaurav, and Kavita Singh. The company has clarified that the agreement is with a third party, assuring there is no conflict of interest and no nominees from the third party are on the company's board of directors. GPT Healthcare, the healthcare arm of the GPT Group, currently owns and operates over 561 beds spread across four state-of-the-art multi-specialty hospitals in the eastern part of the country under the brand name ILS Hospitals. Founded in 2000 in Salt Lake, Kolkata, ILS Hospitals has since expanded its footprint and capabilities. The company's standalone net profit increased 9.8% to Rs 14.82 crore in Q2 FY25 as against Rs 13.50 crore posted in Q2 FY24. However, revenue from operations shed 2.1% YoY to Rs 105.66 in the quarter ended 30 September 2024. Powered by Capital Market - Live

6 months agoCapital Market - Live
Live Market Update
Barometers trade with tiny gains; breadth strong

The key equity indices traded with minor gains in early trade. The Nifty traded above the 24,700 level. FMCG, metal and auto shares advanced while IT, realty and media stocks corrected. Investors are awaiting for the outcome of today's RBI Monetary Policy Committee meeting. At 09:29 IST, the barometer index, the S&P BSE Sensex rose 61.13 points or 0.08% to 81,826.99. The Nifty 50 index added 3.60 points or 0.01% to 24,712. The broader market outperformed the frontline indices. The S&P BSE Mid-Cap index rose 0.09% and the S&P BSE Small-Cap index rallied 0.32%. The market breadth was strong. On the BSE, 2,027 shares rose and 917 shares fell. A total of 107 shares were unchanged. Foreign portfolio investors (FPIs) bought shares worth Rs 8,539.91 crore, while domestic institutional investors (DIIs) were net sellers to the tune of Rs 2,303.64 crore in the Indian equity market on 5 December 2024, provisional data showed. Stocks in Spotlight: GPT Healthcare rose 0.94%. The company has entered into memorandum of Understanding (MoU) for the construction and finishing of a hospital building at Jamshedpur, Jharkhand. Canara Bank added 0.51%. The bank said that the Reserve Bank of India (RBI) has approved to divest its 13% stake in Canara Robeco Asset Management Company and 14.5% in Canara HSBC Life Insurance Company through Initial Public Offer (IPO). The bank has been instructed to adhere to 31 October 2029, timeline for reducing stake in the said entities to 30%. FSN E-Commerce Ventures (Nykaa) shed 0.93%. Nikhil Parikh has resigned from his position as chief executive officer (CEO) of Nykaa Fashion.com Numbers to Track: The yield on India's 10-year benchmark federal paper rose 0.05% to 6.793 as compared with previous close 6.789. In the foreign exchange market, the rupee edged higher against the dollar. The partially convertible rupee was hovering at 84.6600, compared with its close of 84.7100 during the previous trading session. MCX Gold futures for 5 February 2024 settlement was added 0.35% to Rs 76,744. The US Dollar index (DXY), which tracks the greenback's value against a basket of currencies, was up 0.08% to 105.80. The United States 10-year bond yield fell 0.17% to 4.173. In the commodities market, Brent crude for January 2024 settlement lost 06 cents or 0.08% to $72.03 a barrel. Global Markets: Asian stocks traded mixed on Friday. All eyes are on the U.S. nonfarm payrolls report due in the day that may help shape the direction of the Federal Reserve's policy path later this month. In Asia, key economic data releases include India's interest rate decision and Malaysia's foreign reserves. China's November foreign reserves data may also be released today. US stock markets pulled back from record highs on Thursday as investors took a cautious approach ahead of the payrolls report. The S&P 500 declined 0.2%, the NASDAQ Composite fell 0.2%, and the Dow Jones Industrial Average dropped 0.6%. Technology stocks, a major driver of recent market gains, retreated, while economically sensitive sectors like energy, financials, and industrials also lost ground. US initial jobless claims rose to 224,000 for the week ended November 30th, up from the previous week's revised figure of 215,000. The upcoming US nonfarm payrolls report will be closely watched by investors and policymakers alike. A strong reading could reinforce expectations of economic recovery and support further normalization of monetary policy. Meanwhile Bitcoin tumbled from record highs above the coveted $100,000 level, as it was slapped with heavy profit-taking. Powered by Capital Market - Live

6 months agoCapital Market - Live
Spotlight
Stock Alert: GPT Healthcare, Canara Bank, Nykaa, Cummins India, Ramco Cements

Securities in F&O Ban: Granules India and Manapurram Finance shares were banned from F&O trading on 6 December 2024. Stocks to Watch: GPT Healthcare has entered into memorandum of Understanding (MoU) for the construction anf finishing of a hospital building at Jamshedpur, Jharkhand. Canara Bank said that Reserve Bank of India (RBI) has approved to divest its 13% stake inCanara Robeco Asset Management Company and 14.5% in Canara HSBC Life Insurance Company through Initial Public Offer (IPO). The bank has been instructed to adhere to 31 October 2029, timeline for reducing stake in the said entities to 30%. FSN E-Commerce Ventures (Nykaa)'s Nikhil Parikh has resigned from his position as chief executive officer (CEO) of Nykaa Fashion.com Cummins India's chief financial officer, Ajay Shriram Patil has resigned due to personal reasons, with effect from 9 January 2025. Garden Reach Shipbuilder & Engineer (GRSE) has signed contract for the construction and delivery of the second ship from a series of four additional 7,500 DWT multi-purpose vessels in Germany. In September, the company had secured an order for the construction and delivery of four additional multi-purpose vessels of 7,500 DWT each. Ramco Systems has entered a partnership with Hanjin Information Systems and Telecommunication, a subsidiary of the Hanjin Group. Together, both the parties will enable the aviation organizations headquartered in South Korea to digitally transform their M&E and MRO operations. Welspun Living's board approved the scheme of amalgamation between Welspun Home Solutions and Welspun Advanced Materials. Welspun Home Solutions is a subsidiary of Welspun Advanced Materials.Powered by Capital Market - Live

6 months agoCapital Market - Live
Earnings
GPT Healthcare standalone net profit rises 9.78% in the September 2024 quarter

Net profit of GPT Healthcare rose 9.78% to Rs 14.82 crore in the quarter ended September 2024 as against Rs 13.50 crore during the previous quarter ended September 2023. Sales declined 2.15% to Rs 105.66 crore in the quarter ended September 2024 as against Rs 107.98 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales105.66107.98 -2 OPM %22.1722.77 - PBDT25.4923.87 7 PBT20.6919.48 6 NP14.8213.50 10 Powered by Capital Market - Live

7 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of GPT Healthcare Ltd (GPTHEALTH) today?

    The share price of GPTHEALTH as on 19th June 2025 is ₹146.44. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on GPT Healthcare Ltd (GPTHEALTH) share?

    The past returns of GPT Healthcare Ltd (GPTHEALTH) share are
    • Past 1 week: -2.37%
    • Past 1 month: -6.94%
    • Past 3 months: 7.02%
    • Past 6 months: -18.50%
    • Past 1 year: -4.52%
    • Past 3 years: N/A%
    • Past 5 years: -26.41%

  3. What are the peers or stocks similar to GPT Healthcare Ltd (GPTHEALTH)?
  4. What is the dividend yield % of GPT Healthcare Ltd (GPTHEALTH) share?

    The current dividend yield of GPT Healthcare Ltd (GPTHEALTH) is 1.02.

  5. What is the market cap of GPT Healthcare Ltd (GPTHEALTH) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of GPT Healthcare Ltd (GPTHEALTH) is ₹1211.95 Cr as of 19th June 2025.

  6. What is the 52 week high and low of GPT Healthcare Ltd (GPTHEALTH) share?

    The 52-week high of GPT Healthcare Ltd (GPTHEALTH) is ₹208.45 and the 52-week low is ₹126.10.

  7. What is the PE and PB ratio of GPT Healthcare Ltd (GPTHEALTH) stock?

    The P/E (price-to-earnings) ratio of GPT Healthcare Ltd (GPTHEALTH) is 24.28. The P/B (price-to-book) ratio is 5.55.

  8. Which sector does GPT Healthcare Ltd (GPTHEALTH) belong to?

    GPT Healthcare Ltd (GPTHEALTH) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.

  9. How to buy GPT Healthcare Ltd (GPTHEALTH) shares?

    You can directly buy GPT Healthcare Ltd (GPTHEALTH) shares on Tickertape. Simply sign up, connect your demat account and place your order.